Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections

Clinical Pediatrics

Volumn 43, Issue 3, 2004, Pages 239-249

  Schrezenmeir, J ^a   Heller, K ^a   McCue, M ^b   Llamas, C ^b   Lam, W ^b   Burow, H ^c   Kindling Rohracker, M ^c   Fischer, W ^d   Sengespeik, H C ^e   Comer, G M ^b   Alarcon, P ^b  

^a FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^b ABBOTT LABORATORIES   (United States)

^c Private Pediatric Clinic   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PEDIASURE; PROBIOTIC AGENT; PROTECT WITH MART CHOICE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BIFIDOBACTERIUM; CALORIC INTAKE; DIET SUPPLEMENTATION; FECES MICROFLORA; FEMALE; HUMAN; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; WEIGHT GAIN;

ACUTE DISEASE; BACTERIAL INFECTIONS; BIFIDOBACTERIUM; CHILD, PRESCHOOL; CONSTIPATION; DIARRHEA; DIETARY SUPPLEMENTS; FECES; FEMALE; HUMANS; INFANT; LACTOBACILLUS; MALE; OLIGOSACCHARIDES; OTITIS MEDIA; PHARYNGITIS; PROBIOTICS; TONSILLITIS; TREATMENT OUTCOME; VOMITING; WEIGHT GAIN;

EID: 4143134151     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280404300305     Document Type: Article

References (33)

1. McCarthy D, Kluger M, Vander A. Suppression of food intake during infection: is interleukin-1 involved? Am J Clin Nutr. 1985;42:1179-1182.
2. Hoerr R, Young V. Alterations in nutrient intake and utilization caused by-disease. Ann NY Acad Sci. 1987;499:124-131.
3. Scrimshaw N, SanGiovanni J. Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr. 1997;66:464S-477S.
4. Sakata H, Fujita K, Yoshioka H. The effect of antimicrobial agents on fecal flora of children. Antimicrob Agents Chemother. 1986;29:225-229.
5. Gooch W, Blair E, Puopolo A. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. Pediatr Infect Dis J. 1996;15:157-164.
6. Hoberman A, Paradise J, Burch D. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of arnoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. Pediatr Infect Dis J. 1997;16:463-470.
7. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics. 1999;104:e64.
8. Bender S, Cook A, Hall J, et al. Malnutrition: role of the TwoCal HN Med Pass program. MEDSURG Nursing. 2000;9:284-295.
9. Donohue D, Salminen S. Safety of probiotic bacteria. Asia Pacific J Clin Nutr. 1996;5:25-28.
10. Butel MJ, Waligora-Dupriet AJ, Szylit O. Oligofructose and experimental model of neonatal necrotising enterocolitis. Br J Nutr. 2002;87:S213-S219.
11. Kaur IP, Saini A. Probiotics: potential pharmaceutical applications. Eur J Pharm Sci. 2002;15:1-9.
12. Van Niel C, Feudtner C, Garrison M, Christakis D. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics. 2002;109:678-684.
13. Bengmark S. Use of pro-, pre-, and synbiotics in the ICU - future options. Nutr Hosp. 2001;16:239-256.
14. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systemic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr. 2001;33:S17-S25.
15. Duffy LC. Interactions mediating bacterial translocation in the immature intestine. J Nutr. 2000;130:432S-436S.
16. Marteau P, Boutron-Ruault MC. Nutritional advantages of probiotics and prebiotics. Br J Nutr 2002;87:S153-S157.
17. Kaila M, Isolauri E, Soppi E, et al. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Vaccine. 1992;13:310-312.
18. Isolauri E, Joensuu J, Suomalainen H, et al. Improved immunogenicity of oral D × RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine. 1995;13:310-312.
19. Campbell J, Bauer L, Fahey G, et al. Selected fructooligosaccharide (1 Kestone, Nystose, and 1 F-beta-fructofu ra nosy[ nystose) composition of foods and feeds. J Agric Food Chem. 1997;45:3076-3082.
20. Spiegel J, Rose R, Karabell P, et al. Safety and benefits of fructooligosaccharides as food ingredients. Food Tech. 1994:85-89.
21. Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiotics - approaching a definition. Am J Clin Nutr. 2001;73:361S-364S.
22. Arihara K, Ohihara S, Mukai T, et al. Salivacin 140, a novel bacteriocin from Lactobacillus salivarius subsp. salicinius T140 active against pathogenic bacteria. Lett Appl Microbiol. 1996;22:420-424.
23. Fuller R. Probiotics in human medicine. Gut. 1991;32:439-442.
24. Elmer G, Surawicz C, McFarland L. Biotherapeutic agents: a neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA. 1996;275:870-876.
25. Astradsson E, Granath L, Heedman PA, Starkhammar H. Cancer patients hospitalised for palliative reasons. Symptoms and needs presented at a university hospital. Support Care Cancer. 2001;9:97-102.
26. Saarela M, Lahteenmaki L, Crittenden R, et al. Gut bacteria and health foods - the European perspective. Int J Food Micro. 2002;78:99-117.
27. Chandra RK. Interactions of nutrition, infection and immune response. Immunocompetence in nutritional deficiency, methodological considerations and interventions strategies. Acta Paediatr Scand. 1979;68:137-144.
28. Scrimshaw N, SanGiovanni J. Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr. 1997;66:464S-477S.
29. Fisberg M, Maulen I, Vasquez E, et al. Effect of oral supplementation with and without synbiotics on catch-up growth in preschool children. J Pediatr Gastroenterol Nutr. 2000;31:S252 (abstract).
30. Mertsola J, Ziegler T, Ruuskanen O, et al. Recurrent wheezy bronchitis and viral respiratory infections. Arch Dis Child. 1991;66:124-129.
31. Del Mar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. Br Med J. 1997;312:1526-1529.
32. Vanderhoof J, Whitney D, Atonson D, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999;135:564-568.
33. McFarland L, Surawicz C, Greenberg R. A randomized placeb-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994;271:1913-1918.